scanX
Natco Pharma
add_icon

Natco Pharma

893.00
+1.30
(0.15%)
Market Cap
15,994.51 Cr
PE Ratio
10.26
Volume
3,84,128.00
Day High - Low
906.40 - 885.55
52W High-Low
1,059.00 - 726.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
15,994.51 Cr
EPS
105.26
PE Ratio
10.26
PB Ratio
1.84
Book Value
461.80
EBITDA
2,550.50
Dividend Yield
0.67 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
24.74
Debt to Equity
0.05
Analyst Rating and Forecast
- By Refinitiv from10 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy+30.00 %
+30.00 %
Hold
Hold+40.00 %
+40.00 %
Sell
Sell+30.00 %
+30.00 %
Forecast For
Actual

Company News

View All News
Caret
positive
NATCO Pharma Gets CDSCO Nod for Semaglutide Launch8 days ago
NATCO Pharma Limited receives regulatory approval from CDSCO to manufacture and market generic Semaglutide injection in India, with commercial launch planned for March 2026.
neutral
Natco Pharma Gets FDA EIR for Chennai API Unit10 days ago
Natco Pharma receives Establishment Inspection Report from US FDA for its Chennai API facility with Voluntary Action Indicated classification following November 2025 inspection.
positive
Natco Pharma Q3FY26 Results: Revenue ₹705.4 Cr10 days ago
Natco Pharma reported consolidated revenue of ₹705.4 crore and net profit of ₹151.3 crore for Q3FY26. Board declared interim dividend of ₹1.50 per share.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,732.30
#1 4,15,636.80
37.78
#1 54,729.00
9.71
#1 10,980
16.07
60.05
Divis Laboratories
6,293.50
1,67,072.65
67.38
9,712.00
18.67
2,191
-1.02
54.00
Torrent Pharmaceuticals
4,307.60
1,45,788.76
63.13
11,539.40
6.99
1,911
26.24
70.24
Dr Reddys Laboratories
1,307.40
1,09,119.57
19.35
33,741.20
16.73
5,725
-15.28
66.26
Cipla
1,326.50
1,07,150.93
23.90
28,409.50
7.12
5,291
-57.18
39.62
Lupin
2,241.40
1,02,386.88
21.73
22,909.50
13.74
3,306
#1 37.44
61.44
Zydus Life Science
907.95
91,361.02
#1 18.04
23,511.00
18.55
4,615
-0.32
52.14
Mankind Pharma
2,046.60
84,484.69
46.41
12,744.20
#1 20.90
2,007
7.65
42.73
Aurobindo Pharma
1,150.60
66,827.03
19.33
32,345.60
9.43
3,484
7.59
46.03
Alkem Laboratories
5,490.50
65,647.16
26.62
13,458.30
3.70
2,216
1.90
43.77

Automatic Screeners on ScanX

Community
Resistance 1 Breached
Community
Resistance 2 Breached
Growth Rate
Revenue Growth
15.92 %
Net Income Growth
35.66 %
Cash Flow Change
40.05 %
ROE
4.30 %
ROCE
5.57 %
EBITDA Margin (Avg.)
17.06 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
194
218
239
281
395
330
464
676
564
432
432
574
788
575
584
580
487
513
519
513
477
582
828
386
360
427
415
591
611
919
453
513
927
1,160
1,061
796
1,110
1,411
1,435
651
1,287
1,391
1,463
705
Expenses
151
166
185
227
302
248
356
410
324
291
305
276
385
321
323
348
307
301
351
354
327
392
526
273
255
301
307
459
615
489
337
387
559
613
573
491
571
558
567
436
673
758
784
489
EBITDA
42
51
54
54
93
82
108
266
241
140
127
298
403
254
261
232
179
212
168
160
151
190
302
113
105
127
109
132
-5
430
116
127
368
548
487
305
539
853
868
215
614
633
679
217
Operating Profit %
21 %
23 %
22 %
17 %
23 %
24 %
23 %
39 %
43 %
32 %
29 %
51 %
50 %
40 %
41 %
37 %
33 %
39 %
28 %
27 %
28 %
30 %
34 %
23 %
23 %
27 %
19 %
18 %
-3 %
45 %
22 %
22 %
38 %
46 %
44 %
35 %
47 %
59 %
59 %
8 %
45 %
43 %
42 %
25 %
Depreciation
13
13
13
13
12
13
14
14
14
15
16
17
18
18
20
21
22
22
22
25
31
28
29
30
30
34
35
36
38
40
42
42
41
44
44
44
56
44
46
47
98
58
52
46
Interest
9
8
8
4
4
3
4
5
6
4
4
4
3
3
5
6
5
7
6
5
4
4
3
3
4
2
4
5
7
4
4
4
3
4
4
5
6
5
4
4
10
3
13
10
Profit Before Tax
31
38
40
50
77
66
90
248
221
121
107
276
382
232
235
205
152
184
139
129
117
158
271
80
71
91
70
91
-50
386
70
81
324
500
440
256
478
804
818
164
506
572
614
161
Tax
-23
11
11
13
14
19
24
53
44
28
23
59
83
51
54
45
32
41
22
24
24
36
67
17
18
16
5
11
1
65
14
19
49
80
71
44
91
135
142
31
100
92
96
10
Net Profit
53
27
29
37
63
48
66
195
176
94
84
217
300
181
182
159
120
143
118
104
93
122
204
63
53
75
65
80
-51
320
57
62
276
420
369
213
386
669
677
132
406
480
518
151
EPS in ₹
16.41
1.70
9.05
2.13
3.86
2.74
3.79
11.18
10.10
5.59
4.82
12.29
16.26
9.84
9.89
8.65
6.59
7.87
6.55
5.75
5.17
6.74
11.12
3.44
2.91
4.11
3.57
4.41
-2.77
22.55
3.11
3.41
15.11
23.26
20.60
11.88
21.56
37.32
37.81
7.43
22.70
26.84
28.94
8.46
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,384
1,822
2,318
3,715
4,303
4,588
4,792
5,109
5,657
6,906
8,631
Fixed Assets
710
710
833
1,019
1,227
1,584
2,023
2,312
2,427
2,491
2,698
Current Assets
483
837
1,087
2,131
2,347
2,326
2,337
2,497
3,000
4,024
5,270
Capital Work in Progress
129
212
336
480
638
518
223
130
64
137
225
Investments
0
22
32
77
169
112
304
308
392
539
474
Other Assets
545
878
1,116
2,140
2,270
2,373
2,242
2,360
2,774
3,739
5,234
Total Liabilities
1,384
1,822
2,318
3,715
4,303
4,588
4,792
5,109
5,657
6,906
8,631
Current Liabilities
414
493
627
592
729
685
526
710
683
973
944
Non Current Liabilities
119
28
38
47
83
118
143
135
101
80
75
Total Equity
851
1,301
1,653
3,076
3,491
3,785
4,123
4,264
4,874
5,853
7,612
Reserve & Surplus
813
1,261
1,614
3,035
3,453
3,737
4,085
4,227
4,837
5,817
7,571
Share Capital
33
35
35
37
37
36
37
37
37
36
36
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
2
90
-1
-2
7
-9
6
85
21
-62
50
Investing Activities
-120
-176
-299
-1,116
-611
-175
-107
4
-465
-1,026
-1,437
Operating Activities
93
112
346
464
669
417
299
47
849
1,212
1,697
Financing Activities
29
154
-48
651
-51
-251
-186
35
-363
-247
-211
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
48.87 %
48.87 %
48.87 %
48.86 %
48.81 %
48.80 %
48.80 %
48.82 %
48.84 %
49.76 %
49.71 %
49.71 %
49.71 %
49.71 %
49.62 %
49.62 %
49.56 %
49.56 %
49.48 %
49.48 %
FIIs
0.01 %
0.03 %
0.03 %
0.03 %
0.03 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
16.14 %
17.45 %
17.51 %
17.94 %
17.49 %
15.51 %
14.09 %
15.16 %
DIIs
9.64 %
9.16 %
8.99 %
9.23 %
7.55 %
6.75 %
13.70 %
14.93 %
15.38 %
15.02 %
14.01 %
11.23 %
9.70 %
7.87 %
6.75 %
5.57 %
5.65 %
5.82 %
5.87 %
5.39 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
15.66 %
16.47 %
16.56 %
16.54 %
17.48 %
18.45 %
20.13 %
19.83 %
20.24 %
20.20 %
19.49 %
21.24 %
20.60 %
21.59 %
22.60 %
23.34 %
23.68 %
25.22 %
25.84 %
25.38 %
Others
25.83 %
25.47 %
25.56 %
25.34 %
26.14 %
26.00 %
17.37 %
16.42 %
15.54 %
15.02 %
16.79 %
17.82 %
3.85 %
3.39 %
3.52 %
3.53 %
3.61 %
3.89 %
4.72 %
4.58 %
No of Share Holders
85,509
87,667
88,439
88,421
85,828
92,449
1,21,336
1,35,397
1,53,663
1,55,181
1,63,753
2,07,571
2,28,467
2,51,485
3,02,944
3,45,332
4,05,222
4,29,434
4,19,699
4,24,167

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 6.75 8.25 6.25 6.75 5.25 4.5 5.5 9.5 6 0.00
Dividend Yield (%) 0.9 1.44 1.24 0.82 0.69 0.81 0.58 1.19 0.67 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Feb 2021 DIVIDEND Dividend
₹ 1.00 /share
 22 Feb 2021 886.50 793.60
25 Aug 2021 DIVIDEND Dividend
₹ 2.00 /share
 24 Aug 2021 1,010.55 898.85
24 Nov 2021 DIVIDEND Dividend
₹ 0.50 /share
 23 Nov 2021 857.25 809.85
25 Feb 2022 DIVIDEND Dividend
₹ 2.00 /share
 24 Feb 2022 922.65 763.65
22 Aug 2022 DIVIDEND Dividend
₹ 3.50 /share
 19 Aug 2022 751.10 647.30
22 Nov 2022 DIVIDEND Dividend
₹ 0.75 /share
 21 Nov 2022 613.95 569.50
21 Feb 2023 DIVIDEND Dividend
₹ 1.25 /share
 21 Feb 2023 530.70 549.95
22 Aug 2023 DIVIDEND Dividend
₹ 7.00 /share
 22 Aug 2023 877.75 860.55
29 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Sept 2023 902.30 872.95
24 Nov 2023 DIVIDEND Dividend
₹ 1.25 /share
 24 Nov 2023 793.80 789.25
26 Feb 2024 DIVIDEND Dividend
₹ 1.25 /share
 26 Feb 2024 857.30 1,026.90
23 Aug 2024 DIVIDEND Dividend
₹ 3.00 /share
 23 Aug 2024 1,440.35 1,551.35
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 30 Sept 2024 1,440.35 1,413.15
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Nov 2024 1,292.30 1,395.25
27 Nov 2024 DIVIDEND Dividend
₹ 1.50 /share
 27 Nov 2024 1,395.25 1,355.65
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Feb 2025 1,171.00 1,242.45
18 Feb 2025 DIVIDEND Dividend
₹ 1.50 /share
 18 Feb 2025 1,242.45 870.45
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 28 May 2025 809.60 878.65
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 931.05 899.80
19 Aug 2025 DIVIDEND Dividend
₹ 2.00 /share
 19 Aug 2025 899.80 874.45
25 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 25 Sept 2025 855.25 854.20
14 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 14 Nov 2025 800.50 826.05
20 Nov 2025 DIVIDEND Dividend
₹ 1.50 /share
 20 Nov 2025 826.05 830.10
12 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Feb 2026 813.65 850.75
18 Feb 2026 DIVIDEND Dividend
₹ 1.50 /share
 18 Feb 2026 850.75 884.50

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome5 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release9 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication10 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2026
Corporate Action-Board approves DividendFeb 12, 2026
Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 12, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 12, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 12, 2026
Un Audited Financial Results For The Quarter Ending 31St December 2025Feb 12, 2026
Board Meeting Outcome for Out Come Of Board MeetingFeb 12, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 03, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2026
Board Meeting Intimation for Considering The Unaudited Financial Results For The Quarter And Period Ended 31St December 2025 And Declaration Of 3Rd Interim Dividend If Any For FY 2025-26Jan 28, 2026
ClarificationJan 07, 2026
Clarification sought from Natco Pharma LtdJan 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Sustainability Report For The Year 2024-25Jan 05, 2026
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 02, 2025
Announcement under Regulation 30 (LODR)-Credit RatingNov 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 14, 2025
Corporate Action-Board approves DividendNov 14, 2025
Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 14, 2025
Record Date For Payment Of 2Nd Interim Dividend For The FY 2025-26Nov 14, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Board Meeting Intimation for Considering And Approve The Financial Results For The Period Ended September 30 2025 And 2Nd Interim Dividend For The Financial Year Ending 2025-26Nov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 31, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 09, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Oct 03, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Closure of Trading WindowSep 29, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesSep 25, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
JioBlackRock Flexi Cap Fund Direct-Growth
0.31%
20933
0.03%
0.16%
Franklin India Multi-Factor Fund Direct - Growth
0.39%
-12467
-0.29%
0.39%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.39%
1203
-0.01%
0.00%
Nippon India Nifty 500 Quality 50 Index Fund Direct-Growth
0.97%
166
-0.07%
0.97%
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth
0.74%
57
-0.02%
0.03%
DSP Nifty 500 Index Fund Direct-Growth
0.04%
54
0.04%
0.04%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.39%
51
-0.01%
0.39%
Axis Nifty500 Quality 50 Index Fund Direct-Growth
0.95%
-21
-0.06%
0.95%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.13%
9
-0.01%
0.13%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.04%
4
0.00%
0.00%
Baroda BNP Paribas Small Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Motilal Oswal Nifty 500 Momentum 50 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Manufacturing Fund Direct - Growth
0.00%
0
0.00%
0.00%
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund Direct-Growth
1.05%
0
0.00%
-0.03%
Canara Robeco Large and Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Baroda BNP Paribas Business Cycle Fund Direct - Growth
0.80%
0
0.00%
-0.24%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.04%
0
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.39%
0
0.00%
-0.01%
Edelweiss Nifty500 Multicap Momentum Quality 50 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.40%
0
0.00%
0.00%
Groww Nifty Smallcap 250 Index Fund Direct - Growth
0.40%
0
0.00%
-0.01%
Groww Nifty Total Market Index Fund Direct - Growth
0.04%
0
0.00%
0.00%
HDFC BSE 500 Index Fund Direct - Growth
0.04%
0
0.00%
0.00%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.39%
0
0.00%
-0.01%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.10%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
59.20
ATR(14)
Less Volatile
31.55
STOCH(9,6)
Neutral
54.36
STOCH RSI(14)
Overbought
98.74
MACD(12,26)
Bullish
8.63
ADX(14)
Weak Trend
20.21
UO(9)
Bearish
44.36
ROC(12)
Uptrend And Accelerating
6.02
WillR(14)
Neutral
-33.67
Bearish
4
Neutral
3
Bullish
2

About Natco Pharma

Natco Pharma Limited is a vertically integrated pharmaceutical company specializing in the development, manufacturing, and marketing of Finished Dosage Formulations and Active Pharmaceutical Ingredients. The company focuses on niche therapeutic areas and complex products, selling in over 40 countries. Natco operates in the Pharmaceuticals and Agro chemicals segments, with nine...more
Website
https://www.natcopharma.co.in
Chairperson NameV C Nannapaneni
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104